Information Provided By:
Fly News Breaks for November 1, 2017
BCR, BDX
Nov 1, 2017 | 13:01 EDT
Piper Jaffray analyst William Quirk says that post CareFusion, Becton Dickinson is "swaying away from a consistent beat-and-raise story." His remarks follow CareFusion international website checks that continued to suggest little new outside the U.S. product launches during the quarter. The analyst modestly lowered his Street-high Q4 revenue estimate and maintains an Overweight rating on Becton Dickinson with a $213 price target. He views the pending C.R. Bard (BCR) acquisition as "very attractive."
News For BDX;BCR From the Last 2 Days
There are no results for your query BDX;BCR
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.